| Symbol | Company | Weighting |
|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP USD | 5.27% |
| AKRO | AKERO THERAPEUTICS INC | 5.02% |
| RYTM | RHYTHM PHARMACEUTICALS INC | 3.34% |
| NTRA | NATERA INC | 2.97% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.79% |
| ARGX | ARGENX SE ADR | 2.71% |
| BSX | BOSTON SCIENTIFIC | 2.71% |
| ISRG | INTUITIVE SURGICAL INC | 2.69% |
| MCK | MCKESSON CORP | 2.67% |
| ALKS | ALKERMES INC | 2.34% |
| SYK | STRYKER CORP | 2.33% |
| HCA | HCA HOLDINGS INC | 2.29% |
| NUVL | NUVALENT INC | 2.13% |
| EXAS | EXACT SCIENCES CORP | 2.10% |
| IONS | IONIS PHARMACEUTICALS INC | 2.10% |
| TARS | TARSUS PHARMACEUTICALS | 2.04% |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1.99% |
| IDXX | IDEXX LABS CORP | 1.99% |
| SNY | SANOFI- AVENTIS- ADR | 1.95% |
| VRTX | VERTEX PHARMACEUTICALS INC | 1.94% |
| LNTH | LANTHEUS HOLDINGS INC | 1.93% |
| RNA | AVIDITY BIOSCIENCES INC | 1.87% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.79% |
| AZN | ASTRAZENECA PLC-ADR | 1.79% |
| ZTS | ZOETIS INC | 1.74% |
| EW | EDWARDS LIFESCIENCES CORP | 1.71% |
| AMGN | AMGEN CORP | 1.70% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.69% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.63% |
| LLY | ELI LILLY CORP | 1.59% |
| DHR | DANAHER CORP | 1.47% |
| ELV | ELEVANCE HEALTH INC | 1.45% |
| BDX | BECTON DICKINSON & CO | 1.43% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.41% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.35% |
| DNLI | DENALI THERAPEUTICS INC. | 1.32% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 1.26% |
| DXCM | DEXCOM INC | 1.22% |
| MRK | MERCK & CO. NEW | 1.20% |
| UNH | UNITEDHEALTH GROUP INC | 1.19% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.18% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.12% |
| CYTK | CYTOKINETICS INC | 1.09% |
| REGN | REGENERON PHARMACEUTICALS | 1.09% |
| AVTR | AVANTOR, INC. | 1.08% |
| BIIB | BIOGEN INC | 1.05% |
| IMVT | IMMUNOVANT INC | 1.03% |
| NVO | NOVO NORDISK A/S | 1.02% |
| PCVX | VAXCYTE INC | 0.85% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 0.85% |
| APLS | APELLIS PHARMACEUTICALS INC | 0.84% |
| VKTX | VIKING THERAPEUTICS, INC. | 0.77% |
| TNDM | TANDEM DIABETES CARE INC | 0.71% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.69% |
| XNCR | XENCOR INC. | 0.68% |
| DYN | DYNE THERAPEUTICS, INC. | 0.61% |
| KURA | KURA ONCOLOGY INC | 0.49% |
| ARVN | ARVINAS INC USD | 0.46% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.26% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.